“New Cord Blood Bank in Abu Dhabi Promises Medical Progress”

The Department of Health – Abu Dhabi (DoH) and M42, a leading artificial intelligence and cloud computing company, have partnered to establish the Abu Dhabi Biobank, which is set to be the largest hybrid cord blood bank in the Middle East. This development is a significant milestone in positioning Abu Dhabi as a pioneer in life sciences research and development.

The Abu Dhabi Biobank, introduced during the inaugural Abu Dhabi Global Healthcare Week 2024, features a cutting-edge cord blood bank and represents the first phase of a larger biobanking initiative. Located within M42’s Omics Centre of Excellence in Masdar City, this state-of-the-art facility is equipped with advanced automated technology and has a storage capacity that exceeds expectations. The biobank has the capability to store 100,000 cord blood samples and an impressive five million pan-human samples, making it a crucial resource for medical research and therapeutic applications in the years to come.

Cord blood, derived from the umbilical cord after childbirth, contains hematopoietic stem cells (HSCs) that are essential for treating various blood disorders and immune system deficiencies. These stem cells can be transplanted into patients requiring treatment, offering them a chance at better health. The extensive storage capacity of the Abu Dhabi Biobank will significantly increase the likelihood of finding compatible matches for patients in need of HSC transplants, leading to shorter wait times, improved treatment outcomes, and potentially life-saving opportunities for a wider range of individuals.

Additionally, the diverse dataset of the Abu Dhabi Biobank will be invaluable for researchers, enabling them to explore the intricacies of human health and disease. The vast collection of cord blood and pan-human samples will support advancements in personalized medicine, facilitating the development of more targeted and effective treatments.

The Abu Dhabi Biobank not only signifies a triumph in medical storage capacity but also showcases Abu Dhabi’s dedication to fostering a future driven by medical innovation. This collaboration between DoH and M42 reinforces the Emirate’s position as a leader in life sciences and sets the stage for a healthier future for all.